Xylem (NYSE: XYL) reported Q3 EPS of $0.63, $0.04 better than the analyst estimate of $0.59. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.29 billion.

GUIDANCE:

Xylem sees FY2021 EPS of $2.40-$2.50, versus the consensus of $2.58. Xylem sees FY2021 revenue of $5.1-5.2 billion, versus the consensus of $5.3 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.